ALDH18A1 and bladder transitional cell carcinoma: To investigate whether there is a difference in TMB among different risk groups of GPR-TME-score, we explored the level of tumor mutation load in each of their risk groups with the help of CNV data from the TCGA-BLCA cohort to predict the response of different risk groups to immunotherapy.